Position in IDYA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,018,491
+$171,680 QoQ
Shares Held
120,603
+8.4% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 99.94610415992969.ToString("F0")%
Shared 0.ToString("F0")%
None 0.05389584007031334.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEUBERGER BERMAN GROUP LLC holds $1,136,881,142 across 81 Biotechnology names. IDYA ranks #28 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,129 | $330,016,949 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,522 | $246,276,633 | |
| 3 | TECH |
BIO-TECHNE Corp
|
3,340,837 | $174,592,141 | |
| 4 | CAI |
Caris Life Sciences, Inc.
|
3,590,586 | $64,199,677 | |
| 5 | INSM |
INSMED Inc
|
270,700 | $44,264,863 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
443,272 | $33,285,294 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,496 | $30,935,021 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
480,740 | $25,344,612 |
All Filings in IDYA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,018,491 | 120,603 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,846,811 | 111,276 | Shares | Defined | 2026-02-13 | |
| 2024-12-31 | $4,254,043 | 165,527 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,831,347 | 120,939 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,174,259 | 90,409 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $3,675,168 | 83,755 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||